Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
Abstract Mesalazine is a key drug used for remission induction and maintenance therapy in inflammatory bowel disease (IBD). We sometimes encounter patients who develop allergic reactions to the drug and inevitably discontinue treatment. Of 692 patients who received mesalazine for IBD between 2014 an...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/a50c4d8aa4dc4df286985a54519ff870 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|